<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04570813</url>
  </required_header>
  <id_info>
    <org_study_id>20-PP-21</org_study_id>
    <nct_id>NCT04570813</nct_id>
  </id_info>
  <brief_title>Art'Health: Effects of Artistic and Participative Workshops at the MAMAC of Nice on the Health of Seniors</brief_title>
  <acronym>Art'Health</acronym>
  <official_title>Art'Health: Effects of Artistic and Participative Workshops at the MAMAC of Nice on the Health of Seniors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study with two arms, one of which receives an intervention in the form of participative&#xD;
      artistic workshops at the MAMAC and the other was assigned as the control group. Well-being,&#xD;
      Quality of life, Health, Apathy and Olfactory identification scales are proposed before the&#xD;
      intervention, during the intervention at the end of each month (M1, M2, M3), 6 months after&#xD;
      the end of the intervention (M9) and 12 months after the end of the intervention (M15).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>changes of well being level</measure>
    <time_frame>before the intervention, during the intervention at the end of each month (Month1, Month 2, Month 3), 6 months after the end of the intervention (Month 9) and 12 months after the end of the intervention (Month 15)</time_frame>
    <description>well being scale assessment Warwick-Edimbourg Mental Well-Being State (WEMWBS)&#xD;
maximum value : 70 (better outcome) minimum value :14 (worse outcome)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Well Aging</condition>
  <arm_group>
    <arm_group_label>artistic activities</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>participants will do a 3-month cycle of weekly &quot;artistic activities&quot; at the MAMAC Museum,&quot; which are structured 2-h-long art-based workshops</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No artistic activities</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The control group is composed of participants who do not take part in art-based activities,</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Artistic activies</intervention_name>
    <description>12 workshops of artictic activities during 12 weeks</description>
    <arm_group_label>artistic activities</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Be 65 years of age at the time of signing the consent,&#xD;
&#xD;
          2. Having internet access and an electronic tool (smartphone and/or tablet) at home as&#xD;
             repeated assessments will be proposed on a dedicated and secure internet platform,&#xD;
&#xD;
          3. To master the French language,&#xD;
&#xD;
          4. To be available during participatory workshop sessions at MAMAC.&#xD;
&#xD;
          5. Be affiliated to Social Security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Do not master the French language,&#xD;
&#xD;
          2. Severe sensory and/or cognitive impairment identified by the IP and their&#xD;
             representatives during the inclusion interview,&#xD;
&#xD;
          3. Person under guardianship, curatorship or safeguarding of justice,&#xD;
&#xD;
          4. Person unable to give or sign consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Auriane GROS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research and Resources Memory Centre, Nice University Hospital, Nice, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Auriane GROS</last_name>
    <phone>0492034561</phone>
    <email>Auriane.GROS@univ-cotedazur.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Magali PAYNE</last_name>
    <phone>0492034561</phone>
    <email>payne.m@chu-nice.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre MÃ©moire de Ressources et de Recherche, CHU de Nice</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Magali PAYNE</last_name>
      <email>payne.m@chu-nice.fr</email>
    </contact>
    <investigator>
      <last_name>Auriane GROS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 30, 2020</study_first_posted>
  <last_update_submitted>October 2, 2020</last_update_submitted>
  <last_update_submitted_qc>October 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

